February 26, 2018
Vertex names new CMO
Vertex Pharmaceuticals has appointed new medical boss and Executive Vice President of global medicines business, which will be effective in…
Pharmaceuticals, Biotechnology and Life Sciences
Category: Approval
February 26, 2018
Destiny Pharma’s XF-73 could be the first drug approved for the US FDA’s newly defined indication of prevention of post-surgical staphylococcal infection
UK-based developer of anti-microbial drugs, Destiny Pharma, has welcomed the news from the US FDA for acceptance of an Investigational…
February 26, 2018
Bristol-Myers Squibb in expansion of the international immuno-oncology network
Bristol-Myers Squibb on Monday announced that Yale Cancer Center has joined the International Immuno-Oncology Network (II-ON), a global peer-to-peer collaboration…
February 26, 2018
Lilly’s Trulicity(R) (dulaglutide) in combination with an SGLT-2 inhibitor improves blood sugar control in people with Type 2 Diabetes
Eli Lilly’s Trulicity (dulaglutide) significantly improves A1C (average blood sugar concentration over two to three months) when added to ongoing…
February 26, 2018
SOBI reinforces financial department, opens door for new CFO who will join in late spring
Swedish Orphan Biovitrum AB has welcomed its new Chief Financial Officer who will join Sobi in late spring. Henrik Stenqvist…
February 23, 2018
Sanofi in closure of $11.6 billion hemophilia specialist buy
Sanofi’s waiting period to complete the purchase of Bioverativ has came to an end, and will thus expand its hemophilia and other…
February 23, 2018
Gilead’s Executive VP, commerctial operations, to retire
Gilead Sciences will begin a search for new Commercial Operation Executive Vice President in the coming weeks’s, as its current…
February 22, 2018
FDA could extend Allergan, Medicines360’s contraceptive hormone-releasing system Liletta duration
Allergan and Medicines360, a global nonprofit women’s health pharmaceutical company dedicated to expanding access to quality medicines, have announced that…
February 22, 2018
Mylan’s combination HIV treatment available in developing countries as a first-line regimen for people being treated for HIV/AIDS
World’s largest HIV/AIDS drug-maker Mylan has received tentative approval for combination HIV treatment DTG/FTC/TAF under FDA’s PEPFAR program, the company…
February 22, 2018
Novo Nordisk wants to submit its new type 2 diabetes tablet in 2019, first phase trial hits aim
Novo Nordisk has completed the first phase 3a trial, PIONEER 1, with oral semaglutide, for treating type 2 diabetes in…